Roger Barker (Former)
101 – 110 of 130
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro
(
- Contribution to journal › Article
-
Mark
Sleep and circadian rhythm regulation in early Parkinson disease
(
- Contribution to journal › Article
-
Mark
The spectrum of cognitive impairment in Lewy body diseases
(
- Contribution to journal › Scientific review
-
Mark
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
(
- Contribution to journal › Article
-
Mark
Treating Parkinson's disease in the 21st century : can stem cell transplantation compete?
(
- Contribution to journal › Article
-
Mark
Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA)
(
- Contribution to journal › Article
-
Mark
The glial response to intracerebrally delivered therapies for neurodegenerative disorders : is this a critical issue?
(
- Contribution to journal › Scientific review
-
Mark
Quality of life and mild cognitive impairment in early Parkinson's disease : does subtype matter?
(
- Contribution to journal › Article
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
(
- Contribution to journal › Article
-
Mark
Gold nanoparticles explore cells : cellular uptake and their use as intracellular probes
(
- Contribution to journal › Article